Who is sponsoring NCT06655610?

NCT06655610 is sponsored by Psychiatric Research Unit, Region Zealand, Denmark.

What drugs are being tested in NCT06655610?

Interventions in NCT06655610: External Trigeminal Nerve Stimulation, Sham device.

What condition does NCT06655610 study?

NCT06655610 studies ADHD - Attention Deficit Disorder With Hyperactivity.

Is NCT06655610 still recruiting?

NCT06655610 is currently recruiting now. Last updated 9 March 2026.

Last reviewed 2026-03-09 · How we verify

NCT06655610: eTNS4ADHD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

External Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder - Feasibility Trial

Recruiting now NA Last updated 9 March 2026

What this trial tests

NA trial testing External Trigeminal Nerve Stimulation in ADHD - Attention Deficit Disorder With Hyperactivity in 60 participants. Currently enrolling.

Timeline

5 December 2024

Primary endpoint
31 August 2026

25 November 2026

Quick facts

Lead sponsor	Psychiatric Research Unit, Region Zealand, Denmark
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	60
Start date	5 December 2024
Primary completion	31 August 2026
Estimated completion	25 November 2026
Sites	1 location across Denmark

Drugs / interventions tested

External Trigeminal Nerve Stimulation
Sham device — full drug profile →

Conditions studied

ADHD - Attention Deficit Disorder With Hyperactivity — all drugs for ADHD - Attention Deficit Disorder With Hyperactivity →

Sponsor

Psychiatric Research Unit, Region Zealand, Denmark

Who can join

Adults 7 to 17, any sex, with ADHD - Attention Deficit Disorder With Hyperactivity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will assess the use of the Monarch eTNS device as a non-pharmacological treatment for patients aged 7 to 17 years with ADHD. The investigators will compare the eTNS device to a sham device. Participants will use the device for four weeks during night time. During the trial, participants will receive different questionaires to assess symptoms and will also keep a logbook to record their experience with the device. At the end of trial, the investigators will assess what the families thought of the device, and whether it is indeed feasible to further explore the effect of the device in a larger clinical trial.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

External trigeminal nerve stimulation versus sham stimulation for attention deficit hyperactivity disorder in children and adolescents aged 7-17 years: study protocol for a pilot and feasibility randomized clinical trial.
Edemann-Callesen H, Huus CL, Karstoft C, Bjarnadóttir E, et al · · 2025 · PMID 40518459 · DOI 10.1007/s00787-025-02786-7

Verify or expand the search:

Other recruiting trials for ADHD - Attention Deficit Disorder With Hyperactivity

Currently open trials in the same condition.

NCT06871488 — Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants · Phase 4 · recruiting
NCT07281092 — Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) · NA · recruiting
NCT07203469 — Where Wild Things Grow: Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth · NA · recruiting
NCT07139210 — EFFECT OF PERCEPTUAL-MOTOR TRAINING ON COGNITIVE FUNCTIONS, MOTOR ABILITIES AND QUALITY OF LIFE IN CHILDREN WITH ATTENTI · NA · active not recruiting
NCT06910605 — Exploring Parameters of Driving Simulation in Relation to Drug Holidays in ADHD Patients · NA · recruiting

Other Psychiatric Research Unit, Region Zealand, Denmark trials

Trials by the same sponsor.

NCT05562232 — The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms · NA · recruiting
NCT05172375 — Development of a Model for Shared Care in the Interface Between General Practice and Mental Health Care · NA · unknown
NCT05243160 — Medication Reviews in Severe Mental Illness · NA · completed
NCT05018312 — Modified Collaborative Assessment VS Standard Assessment on Readiness For Psychotherapy Among Patients With Anxiety · NA · unknown
NCT05516238 — Systematic Use of Telepsychiatry for Outpatients · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06655610 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Psychiatric Research Unit, Region Zealand, Denmark
Last refreshed: 9 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06655610.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing